Structural basis for ligand recognition of the neuropeptide Y Y


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
02 02 2021
Historique:
received: 01 06 2020
accepted: 08 01 2021
entrez: 3 2 2021
pubmed: 4 2 2021
medline: 2 3 2021
Statut: epublish

Résumé

The human neuropeptide Y (NPY) Y

Identifiants

pubmed: 33531491
doi: 10.1038/s41467-021-21030-9
pii: 10.1038/s41467-021-21030-9
pmc: PMC7854658
doi:

Substances chimiques

Benzamides 0
JNJ-31020028 0
Peptide Hormones 0
Piperazines 0
Pyridines 0
Receptors, Neuropeptide Y 0
neuropeptide Y2 receptor 0
benzamide 6X80438640
pyridine NH9L3PP67S

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

737

Références

Front Endocrinol (Lausanne). 2013 Feb 04;4:5
pubmed: 23382728
Angew Chem Int Ed Engl. 2015 Jun 15;54(25):7446-9
pubmed: 25924821
J Pept Sci. 2000 Mar;6(3):97-122
pubmed: 10759209
J Clin Invest. 2002 Apr;109(7):915-21
pubmed: 11927618
Bone. 2012 Feb;50(2):430-6
pubmed: 22008645
J Neurosci. 1998 Apr 15;18(8):3014-22
pubmed: 9526018
Biochemistry. 2017 Jun 6;56(22):2794-2802
pubmed: 28345933
ACS Chem Biol. 2012 Nov 16;7(11):1848-57
pubmed: 22894855
ChemMedChem. 2017 Jan 5;12(1):75-85
pubmed: 27874262
Neuropeptides. 2004 Aug;38(4):213-24
pubmed: 15337373
Psychopharmacology (Berl). 2010 Feb;208(2):265-77
pubmed: 19953226
Nature. 2019 Aug;572(7767):80-85
pubmed: 31243364
Nature. 2012 Mar 21;485(7398):327-32
pubmed: 22437504
Mol Pharmacol. 2018 Apr;93(4):387-401
pubmed: 29436493
Expert Opin Ther Pat. 2009 Oct;19(10):1401-15
pubmed: 19743896
Nat Struct Mol Biol. 2016 Apr;23(4):293-9
pubmed: 26950369
EMBO Mol Med. 2010 Nov;2(11):429-39
pubmed: 20972986
J Biol Chem. 2003 Mar 21;278(12):10562-71
pubmed: 12524448
Nat Protoc. 2009;4(5):706-31
pubmed: 19390528
Biochemistry. 2013 Nov 12;52(45):7987-98
pubmed: 24111902
Structure. 2012 Jun 6;20(6):967-76
pubmed: 22681902
Trends Neurosci. 1997 Jul;20(7):294-8
pubmed: 9223221
Mol Pharmacol. 2018 Apr;93(4):323-334
pubmed: 29367257
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5552-6
pubmed: 21802951
Nature. 2013 Feb 14;494(7436):185-94
pubmed: 23407534
Mol Pharmacol. 2010 Jan;77(1):46-57
pubmed: 19837904
Regul Pept. 1996 Sep 16;65(3):165-74
pubmed: 8897639
Protein Cell. 2018 Jul;9(7):659-663
pubmed: 29039033
Regul Pept. 2010 Aug 9;163(1-3):120-9
pubmed: 20471432
J Physiol. 2009 Jan 15;587(1):19-25
pubmed: 19064614
J Biol Chem. 2007 Mar 9;282(10):7543-51
pubmed: 17204471
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Peptides. 2006 Dec;27(12):3202-7
pubmed: 16959374
J Med Chem. 2016 Apr 14;59(7):3409-17
pubmed: 26985967
Nature. 2002 Aug 8;418(6898):650-4
pubmed: 12167864
Cell. 2015 May 7;161(4):833-44
pubmed: 25913193
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):368-80
pubmed: 22505257
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Br J Pharmacol. 2008 Feb;153(3):420-31
pubmed: 17828288
Int J Obes Relat Metab Disord. 2002 Mar;26(3):281-98
pubmed: 11896483
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
Nature. 2018 Apr;556(7702):520-524
pubmed: 29670288
Eur J Pharmacol. 2016 Apr 5;776:64-70
pubmed: 26875634
Alcohol. 2011 Sep;45(6):567-76
pubmed: 21145691
J Pept Sci. 2011 Apr;17(4):233-46
pubmed: 21351324

Auteurs

Tingting Tang (T)

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.

Christin Hartig (C)

Institute of Biochemistry, Faculty of Life Sciences, Leipzig University, Brüderstr. 34, D 04103, Leipzig, Germany.

Qiuru Chen (Q)

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.
School of Life Science and Technology, ShanghaiTech University, 393 Hua Xia Zhong Road, Shanghai, 201210, China.

Wenli Zhao (W)

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.

Anette Kaiser (A)

Institute of Biochemistry, Faculty of Life Sciences, Leipzig University, Brüderstr. 34, D 04103, Leipzig, Germany.

Xuefeng Zhang (X)

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.

Hui Zhang (H)

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.

Honge Qu (H)

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.
School of Life Science and Technology, ShanghaiTech University, 393 Hua Xia Zhong Road, Shanghai, 201210, China.

Cuiying Yi (C)

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.

Limin Ma (L)

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.

Shuo Han (S)

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.

Qiang Zhao (Q)

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China. zhaoq@simm.ac.cn.
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China. zhaoq@simm.ac.cn.
CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences, Beijing, 100101, China. zhaoq@simm.ac.cn.
School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, 310024, China. zhaoq@simm.ac.cn.

Annette G Beck-Sickinger (AG)

Institute of Biochemistry, Faculty of Life Sciences, Leipzig University, Brüderstr. 34, D 04103, Leipzig, Germany. abeck-sickinger@uni-leipzig.de.

Beili Wu (B)

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China. beiliwu@simm.ac.cn.
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China. beiliwu@simm.ac.cn.
School of Life Science and Technology, ShanghaiTech University, 393 Hua Xia Zhong Road, Shanghai, 201210, China. beiliwu@simm.ac.cn.
CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences, Beijing, 100101, China. beiliwu@simm.ac.cn.
School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, 310024, China. beiliwu@simm.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH